medigraphic.com
Colegio de Medicina Interna de México.

2008, Number 4

<< Back Next >>

Med Int Mex 2008; 24 (4)

Mucosal oral Candida carriers: CHROMagar Candida categorization of 35 strains

Jaimes AA, Hernández PF, Martínez HE, Rodríguez CAA, Arenas GR

Language: Spanish
References: 26
Page: 262-266
PDF size: 167.98 Kb.


ABSTRACT

Background: Asymptomatic carriers of oral Candida have been reported in 17 to 75% of individuals. Identification of yeasts can be made by different methods. Chromogenic methods have been promoted recently.
Objective: To classify isolated Candida species with a chromogenic test (CHROMagar) in asymptomatic carriers. The study was conducted in mycology section of a general hospital in Mexico City.
Patients and methods: A descriptive and transversal study was practiced in a group of adults of both sexes attending the mycology service in a parallel protocol. [¿?]
Results: We studied 35 cases without clinical manifestations of oral candidiasis, 13 male (37.1%) and 22 female (62.8%), with an age range of 20 to 83 years. Eighteen (51.4%) cases were asymptomatic Candida carriers. Candida albicans was isolated in 8 (44.4%) individuals and Candida tropicalis in 4 (22.2%).
Conclusions: Frequency of oral Candida carriers is high; C. albicans was the most isolated species. Chromogenic methods allow an easy and quick identification of these yeasts.


REFERENCES

  1. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J 2002;78(922):455-9.

  2. Rindum JL, Stenderup A, Holmstrup P. Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med 1994;23(9):406-12.

  3. Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearence, colonization, or candidiasis? J Dent Res 1995;74(5):1152-61.

  4. Lynch DP. Oral candidiasis. History, classification, and clinical presentation. Oral Surg Oral Med Oral Pathol 1994;78(2):189-93.

  5. Arenas R. Micología médica ilustrada. 2ª ed. México: McGraw- Hill Interamericana. 2003;pp:189-203.

  6. Odds FC. Introduction and historical note in candidosis. 2nd ed. London: Bailleré Tindall 1988:pp:1-6.

  7. Balleste R, Arteta Z, Fernández N. Evaluación del medio cromógeno CHROMagar CandidaTM para la identificación de levaduras de interés médico. Rev Med Uruguay 2005;21:186-93.

  8. Goldschmidt MC, Fung DY, Grant R, White J, Brown T. New aniline blue dye medium for rapid identification and isolation of Candida albicans. J Clin Microbiol 1991;29(6):1095-9.

  9. Hoppe JE, Frey P. Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans. Eur J Clin Microbiol Infect Dis 1999;18(3):188-91.

  10. Bauters TG, Moerman M, Vermeersch H, Nelis HJ. Colonization of voice prostheses by albicans and non-albicans Candida species. Laryngoscope 2002;112(4):708-12.

  11. Waller J, Koenig H, Debruyne M, Contant G. Evaluation d’un nouveau milieu isolement des levures et de diagnostique rapide de Candida albicans. Rev Fr Lab. 1993;252:89-92.

  12. Freydière AM, Buchaille L, Gille Y. Comparison of three commercial media for direct identification and discrimination of Candida species in clinical specimens. Eur J Clin Microbiol Infect Dis 1997;16(6):464-7.

  13. Cooke VM, Miles RJ, Price RG, Midgley G, et al. New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol 2002;68(7):3622-7.

  14. Bernal S, Martín Mazuelos E, Garcia M, Aller AI, et al. Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis 1996;24(4):201-4.

  15. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994;32(8):1923-9.

  16. Scarparo C, Piccoli P, Ricordi P, Scagnelli M. Comparative evaluation of two commercial chromogenic media for detection and presumptive identification of urinary tract pathogens. Eur J Clin Microbiol Infect Dis 2002;21(4):283-9.

  17. Momani OM. Cost-effectiveness and efficacy of CHROMagar Candida medium in clinical specimens. East Mediterr Health J 2000;6(5-6):968-78.

  18. Ramírez AV, Mosqueda TA, Hernández LLH. Estudio epidemiológico de las lesiones de la mucosa bucal. México: Taller editorial CBS, 1986;pp:60-75.

  19. Holmstrup P, Axéll T. Classification and clinical manifestations of oral yeast infections. Acta Odontol Scand 1990;48(1):57-59.

  20. Axéll T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Rev Suppl 1976;36:1-103.

  21. Crivelli MR, Domínguez FV, Adler IL, Kesler A. Frecuencia y distribución de las lesiones orales en pacientes de la tercera edad. Rev Asoc Odontol Argent 1990;78(1):55-58.

  22. Salazar M, Sacsaquispe SJ. Presencia de hifas de Candida en adultos con mucosa oral clínicamente saludable. Rev Estomatol Herediana. 2005;15(1):54-59.

  23. Li L, Redding S, Dongari-Bagtzoglou AJ. Candida glabrata and emerging oral opportunistic pathogen. J Dent Res 2007;86(3):204-15.

  24. Winner HI, Hurley R. Candida albicans. London: J and A Churchill, 1964.

  25. Tapper-Jones LM, Aldred MJ, Walker DM, Hayes TM. Candida Infections and populations of Candida albicans in mouth of diabetics. J Clin Pathol 1981;34(7):706-11.

  26. Arendorf TM, Walker DM. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980;25(1):1- 10.




2020     |     www.medigraphic.com